UBS ASSET MANAGEMENT AMERICAS INC - BLUEBIRD BIO INC ownership

BLUEBIRD BIO INC's ticker is BLUE and the CUSIP is 09609G100. A total of 197 filers reported holding BLUEBIRD BIO INC in Q3 2021. The put-call ratio across all filers is 1.22 and the average weighting 0.0%.

Quarter-by-quarter ownership
UBS ASSET MANAGEMENT AMERICAS INC ownership history of BLUEBIRD BIO INC
ValueSharesWeighting
Q3 2023$411,425
+490.6%
135,337
+517.8%
0.00%
Q2 2023$69,6580.0%21,9050.0%0.00%
Q1 2023$69,658
-53.6%
21,905
+0.9%
0.00%
Q4 2022$150,205
-100.0%
21,706
-66.8%
0.00%
Q1 2022$317,137,000
-51.5%
65,3890.0%0.00%
Q4 2021$653,237,000
-51.0%
65,389
-6.2%
0.00%
-100.0%
Q3 2021$1,331,891,000
-37.3%
69,696
+5.0%
0.00%0.0%
Q2 2021$2,123,410,000
-22.5%
66,398
-27.0%
0.00%0.0%
Q1 2021$2,741,147,000
-87.0%
90,917
-81.3%
0.00%
-90.0%
Q4 2020$21,044,277,000
+16.4%
486,348
+45.1%
0.01%0.0%
Q3 2020$18,085,172,000
-11.4%
335,221
+0.3%
0.01%
-16.7%
Q2 2020$20,409,091,000
+50.3%
334,356
+13.1%
0.01%
+20.0%
Q1 2020$13,581,595,000
-56.8%
295,509
-17.4%
0.01%
-47.4%
Q4 2019$31,405,638,000
-16.6%
357,899
-12.7%
0.02%
-24.0%
Q3 2019$37,661,167,000
-17.3%
410,163
+14.6%
0.02%
-21.9%
Q2 2019$45,521,955,000
-34.6%
357,877
-19.1%
0.03%
-38.5%
Q1 2019$69,577,777,000
+50.0%
442,241
-5.4%
0.05%
+30.0%
Q4 2018$46,391,477,000
-23.0%
467,656
+13.3%
0.04%
-11.1%
Q3 2018$60,244,418,000
+428.8%
412,633
+468.5%
0.04%
+400.0%
Q2 2018$11,391,590,000
+5.7%
72,581
+14.9%
0.01%0.0%
Q1 2018$10,782,180,000
-12.2%
63,146
-8.4%
0.01%
-10.0%
Q4 2017$12,275,364,000
-60.4%
68,924
-69.4%
0.01%
-64.3%
Q3 2017$30,966,519,000
+24.7%
225,457
-4.6%
0.03%
+16.7%
Q2 2017$24,829,512,000
+54.1%
236,359
+33.4%
0.02%
+50.0%
Q1 2017$16,111,388,000
+112788.1%
177,243
-23.4%
0.02%0.0%
Q4 2016$14,272,000
-12.8%
231,292
-4.2%
0.02%
-11.1%
Q3 2016$16,361,000
+158.9%
241,394
+65.3%
0.02%
+157.1%
Q2 2016$6,320,000
-5.7%
145,991
-7.4%
0.01%
-12.5%
Q1 2016$6,701,000
-33.3%
157,666
+0.8%
0.01%
-27.3%
Q4 2015$10,049,000
-31.5%
156,472
-8.8%
0.01%
-31.2%
Q3 2015$14,673,000
-66.6%
171,508
-34.3%
0.02%
-61.9%
Q2 2015$43,951,000
-33.6%
261,038
-52.3%
0.04%
-34.4%
Q1 2015$66,157,000
+37.1%
547,795
+4.1%
0.06%
+39.1%
Q4 2014$48,250,000
+252.2%
526,069
+37.8%
0.05%
+228.6%
Q3 2014$13,700,000
-5.8%
381,841
+1.3%
0.01%
-6.7%
Q2 2014$14,542,000
+119.2%
377,039
+29.2%
0.02%
+114.3%
Q1 2014$6,634,000
+31.3%
291,747
+21.2%
0.01%
+16.7%
Q4 2013$5,053,000
-23.6%
240,791
-1.9%
0.01%
-25.0%
Q3 2013$6,615,000245,3710.01%
Other shareholders
BLUEBIRD BIO INC shareholders Q3 2021
NameSharesValueWeighting ↓
Monashee Investment Management LLC 125,000$13,131,0005.55%
Cormorant Asset Management, LP 275,000$28,889,0004.79%
Eventide Asset Management 569,700$59,847,0003.73%
Crosspoint Capital Strategies, LLC 28,937$3,040,0002.66%
Casdin Capital, LLC 65,000$6,828,0002.53%
ARK Investment Management 119,683$12,573,0002.45%
RTW INVESTMENTS, LP 104,383$10,965,0002.31%
Taylor Wealth Management Partners 38,368$4,031,0001.82%
First Light Asset Management, LLC 33,780$3,549,0001.19%
Atika Capital Management LLC 25,000$2,627,0000.92%
View complete list of BLUEBIRD BIO INC shareholders